Overcoming the health system barriers to early diagnosis and management of multidrug-resistant tuberculosis in a rural setting in North India

Author:

Bashar Mohammad AbuORCID,Aggarwal Arun,Bhattacharya Sudip

Abstract

India contributes a quarter of the global burden of multidrug-resistant tuberculosis (MDR-TB) and has inadequate diagnostic infrastructure and institutional capacities for drug susceptibility testing. Subsequently, this leads to a large number of undetected and untreated cases of MDR-TB. In this report, we describe a case of a 55-year-old man from rural North India presenting with complaints of continued symptoms of chronic cough, fever and dyspnoea despite being recently diagnosed with recurrent tuberculosis and receiving treatment from the local community health centre. MDR-TB was suspected, but confirmatory diagnostic capabilities were not available in the local setting. The patient was finally diagnosed with MDR-TB. Treatment was coordinated by the district tuberculosis programme officer. Through this case, we describe the various barriers to detecting MDR-TB in the rural regions of India. Prompt identification of patients with presumptive MDR-TB, diagnosis of the disease and initiation of treatment are crucial to preventing disease transmission and reducing morbidity and mortality.

Publisher

BMJ

Subject

General Medicine

Reference27 articles.

1. World Health Organization . Global tuberculosis report 2019, 2019. Available: https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng.pdf [Accessed 13 Dec 2019].

2. Programmes and principles in treatment of multidrug-resistant tuberculosis;Mukherjee;The Lancet,2004

3. World Health Organization . Multidrug and extensively drug-resistant TB (M/XDR-TB), 2010. global report on surveillance and response, 2010. Available: http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf [Accessed 10 May 2019].

4. World Health Organization . Global tuberculosis control, 2016. Available: www.who.int/tb/publications/global_report/en/Geneva,Switzerland [Accessed 10 May 2019].

5. Why are tuberculosis patients not treated earlier? A study of informal health practitioners in Bangladesh

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3